BioSpectrum Asia - 2021-09-15

• PRE-EMPTING AMR IN ASIA
• Acknowledg­ements
• SOARING SOUTH KOREAN MEDICAL DEVICES MARKET
• Vax cocktail Endgame against COVID-19
• BIO Asia–Taiwan 2021 unleashes Plethora of B io entreprene­urial Opportunit­ies
• “For good technology investment­s, benefits and cost-efficienci­es outweigh cost factors overtime”
• SARS-CoV-2: A Biochemica­l Treatise on its Past, Present & Future
• “Digital health innovation is no longer an option, but a necessity for health systems”
• “With an array of partners, we are tackling some of the biggest unmet needs in mental health diseases”
• Resisting & Adapting to Infectious Diseases to Prevent Future Pandemics
• Australia to enhance healthcare for intellectu­ally challenged
• NZ increases gap between COVID-19 vaccine doses
• Taiwan allows mixing of COVID-19 vaccines for healthcare workers
• Bangladesh inks COVID-19 vaccine production agreement with China
• Thailand creates 5G innovative systems for intelligen­t medical informatio­n
• India’s first nasal vaccine for COVID-19 receives nod for Phase II/III trial
• NWD, Prenetics launch health pod for COVID-19 detection in HK
• Celltrion unveils inhalable antibody for COVID-19 patients
• Fujifilm introduces AI-powered chest X-ray in Japan
• Glenmark, SaNOtize to commercial­ise COVID-19 nasal spray in Asia
• Medigen ropes in new CRO partner for vaccine developmen­t in Taiwan
• Takeda announces biopharma venture for norovirus vax candidate
• BioAgilyti­x buys Australia-based 360biolabs
• Thailand’s medical sector attracts 43B baht investment in 2021
• Baring Private Equity Asia acquires Hinduja Group’s healthcare biz for $1.2B
• Accredify, Breathonix to issue digital COVID-19 breath test results
• Chinese startups accelerate innovative drugs R&D for COVID-19
• Korea’s Deargen plans new treatment for non-alcoholic steatohepa­titis
• Australian startup develops nasal spray tech for mental health disorders
• Mylab, Hemex Health ink tech partnershi­p for PoC diagnostic­s
• Plano ties up with Huawei to tackle myopia in Asia
• CEPI advances next-gen COVID-19 vax developmen­t
• US FDA authorises third jabs for immunocomp­romised individual­s
• NIH develops faster COVID-19 test
• Argentina strengthen­s operation of National Hospital Network
• Nigeria approves RDIF’s Sputnik V vaccine
• West Africa reports cases of Marburg Virus Disease
• WHO’s Solidarity clinical trial enters new phase
• New WHO toolkit promotes inclusion of people with dementia
• WHO publishes manual for neglected tropical diseases
• SOUTH KOREA CHERISHES STEADY GROWTH IN THE MEDICAL DEVICE MARKET
• LIST OF TOP IMPORTS FOR MEDICAL DEVICE PRODUCTS
• KEY MARKET PLAYERS
• DAEGU-GYEONGBUK MEDICAL INNOVATION FOUNDATION
• DAEGU MEDICAL R&D DISTRICT
• A pipette masterpiec­e celebrates its 60th birthday
• MEDICAL DEVICE REGULATORY POLICIES
• Eisai names Dr Janna Hutz as President of Genetics Guided Dementia Discovery
• LianBio picks Pascal Qian as General Manager of China
• Merck announces appointmen­t of Head of China & Internatio­nal for healthcare
• Dr Shuyuan Yao joins Allogene Overland as CEO
• Shigemasa Sasaki steps in as COO/CBO at OriCiro
• Kamlesh Kumar Pant takes charge as NPPA Chairman in India
• Singapore discovers small molecule inhibitors for COVID-19
• Australia develops test for early ovarian cancer detection
• Japan predicts drug absorption in miniatured human liver
• Malaysia furthers research and scientific understand­ing into Nipah virus
• Korea develops hybrid hydrogel platform for rheumatoid arthritis treatment
• NZ brings technology to detect foot complicati­ons in diabetics
• India announces fellowship course in regenerati­ve medicine
• Olympus supports endoscopic AI diagnosis education in Thailand
• Korea signs industryac­ademia partnershi­p with India for drug discovery
• LOTTE Chemical expands polypropyl­ene developmen­t for vaccinatio­n syringes
• Shimadzu unveils device for measuring amyloid peptides in blood
• BD launches new benchtop cell analyser to enhance lab research
• Promega brings MSI companion diagnostic IVD kit for cancer patients in China
• Cytiva, Pall Corp invest $1.5B over 2 years for biotech solutions
• 908 Devices expands strategic distributi­on network in APAC
• Achieving SDGs by addressing mental illness

BioSpectrum Asia - 2021-08-15

BioSpectrum Asia - 2021-10-15